Gunter et al. [103] conducted a retrospective analysis involving 875 postmenopausal breast cancer patients and 839 volunteers and found significantly reduced levels of adiponectin in the blood of breast cancer patients, concurrent with a decrease in adiponectin levels in CAAs [104,105]. This evidence concerns the gene ADIPOQ and breast cancer.